CA2509023A1 — Multilayer dosage forms containing nsaids and triptans
Assigned to Aralez Pharmaceuticals Canada Inc · Expires 2004-07-22 · 22y expired
What this patent protects
The present invention is directed to multilayer pharmaceutical tablets in which an NSAID and a triptan are present in separate and distinct layers. Th e layers are in a side-by-side configuration, which allows the dissolution of triptan and NSAID to occur independently and immedi…
USPTO Abstract
The present invention is directed to multilayer pharmaceutical tablets in which an NSAID and a triptan are present in separate and distinct layers. Th e layers are in a side-by-side configuration, which allows the dissolution of triptan and NSAID to occur independently and immediately.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.